David Dai
Stock Analyst at UBS
Total Price Targets
15
Stocks Covered
10
Sectors
Healthcare
Most Recent
Mar 13, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by David Dai
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| KURA | Kura Oncology, Inc. | $15.00 | $8.80 | +70.4% | 2 | Mar 13, 2026 |
| JANX | Janux Therapeutics, Inc. | $57.00 | $14.35 | +297.4% | 2 | Dec 2, 2025 |
| NUVL | Nuvalent, Inc. | $132.00 | $99.45 | +32.7% | 2 | Oct 31, 2025 |
| SNDX | Syndax Pharmaceuticals, Inc. | $35.00 | $19.18 | +82.5% | 2 | Jul 15, 2025 |
| IOVA | Iovance Biotherapeutics, Inc. | $2.00 | $3.40 | -41.3% | 2 | May 16, 2025 |
| IDYA | IDEAYA Biosciences, Inc. | $50.00 | $28.27 | +76.9% | 1 | Oct 24, 2024 |
| CGON | CG Oncology, Inc. Common stock | $60.00 | $66.29 | -9.5% | 1 | Oct 24, 2024 |
| NRIX | Nurix Therapeutics, Inc. | $35.00 | $16.83 | +108.0% | 1 | Oct 24, 2024 |
| CGEM | Cullinan Therapeutics, Inc. | $30.00 | $13.48 | +122.5% | 1 | Oct 24, 2024 |
| CATX | Perspective Therapeutics, Inc. | $20.00 | $3.90 | +413.5% | 1 | Oct 24, 2024 |
Recent Activity
- Mar 13, 2026— Set$15.00price target onKURA(Kura Oncology, Inc.)
- Dec 2, 2025— Set$57.00price target onJANX(Janux Therapeutics, Inc.)
- Oct 31, 2025— Set$132.00price target onNUVL(Nuvalent, Inc.)
- Jul 15, 2025— Set$35.00price target onSNDX(Syndax Pharmaceuticals, Inc.)
- May 16, 2025— Set$2.00price target onIOVA(Iovance Biotherapeutics, Inc.)
- Oct 24, 2024— Set$69.00price target onJANX(Janux Therapeutics, Inc.)
- Oct 24, 2024— Set$50.00price target onIDYA(IDEAYA Biosciences, Inc.)
- Oct 24, 2024— Set$27.00price target onKURA(Kura Oncology, Inc.)
- Oct 24, 2024— Set$60.00price target onCGON(CG Oncology, Inc. Common stock)
- Oct 24, 2024— Set$35.00price target onNRIX(Nurix Therapeutics, Inc.)
- Oct 24, 2024— Set$100.00price target onNUVL(Nuvalent, Inc.)
- Oct 24, 2024— Set$30.00price target onCGEM(Cullinan Therapeutics, Inc.)
- Oct 24, 2024— Set$37.00price target onSNDX(Syndax Pharmaceuticals, Inc.)
- Oct 24, 2024— Set$17.00price target onIOVA(Iovance Biotherapeutics, Inc.)
- Oct 24, 2024— Set$20.00price target onCATX(Perspective Therapeutics, Inc.)
Frequently Asked Questions
Who is David Dai?
David Dai is a stock analyst at UBS covering 10 stocks primarily in Healthcare. They have issued 15 price targets since Oct 24, 2024.
What stocks does David Dai cover?
David Dai currently covers 10 stocks, including KURA, JANX, NUVL, SNDX, IOVA.
What is David Dai's latest price target?
David Dai's most recent price target was $15.00 on KURA (Kura Oncology, Inc.), set on Mar 13, 2026.
What is David Dai's highest price target?
David Dai's highest issued price target is $132.00 on NUVL, set on Oct 31, 2025.
More Analysts at UBS
Coverage based on publicly published price targets. Not investment advice.